An observational cohort study to evaluate the risk of adverse pregnancy outcomes in patients treated with etanercept compared to those not treated with etanercept or other biologics using merged data from Sweden, Denmark and Finland

13/08/2017
01/04/2024
EU PAS number:
EUPAS20081
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Enbrel PASS protocol_B1801396_v 3

English (1.05 MB - PDF) View document
Study results
Study results

Final report for PASS study B1801396 version 3.0 final

English (1.65 MB - PDF) View document
Study report
Study report

Appendix Final report for Etanercept PASS study B1801396_ version 3.0_Final

English (2.22 MB - PDF) View document
Other information